Zobrazeno 1 - 10
of 12
pro vyhledávání: '"AM Schelen"'
Publikováno v:
Blood. 87:132-140
Signal transduction from the granulocyte colony-stimulating factor receptor (G-CSF-R) occurs via multiple pathways, one of which involves activation of p21Ras and mitogen-activated protein kinase. The SH2 domain-containing proteins Shc and GRB2 have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78a126d07fc03afb9c52a782b825e4c2
https://doi.org/10.1182/blood.v87.1.132.bloodjournal871132
https://doi.org/10.1182/blood.v87.1.132.bloodjournal871132
Autor:
Jp, Koning, Aa, Soede-Bobok, Am, Schelen, Smith L, van Leeuwen D, VALERIA SANTINI, Bm, Burgering, Jl, Bos, Lowenberg B, Ip, Touw
Publikováno v:
Europe PubMed Central
The membrane-distal region of the cytoplasmic domain of human granulocyte colony-stimulating factor receptor (G-CSF-R) contains four conserved tyrosine residues: Y704, Y729, Y744, and Y764. Three of these (Y729, Y744, and Y764) are located in the C-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::03639949ad0e4affd0ea91e1e78222d5
https://pubmed.ncbi.nlm.nih.gov/9490675
https://pubmed.ncbi.nlm.nih.gov/9490675
Autor:
Ebeling SB; Jordan Laboratory for Hemato-Oncology, Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Simonetti ER, Borst HP, Blok A, Schelen AM, Braakman E, Ederveen J, Hagenbeek A
Publikováno v:
Gene therapy [Gene Ther] 2003 Oct; Vol. 10 (21), pp. 1800-6.
Autor:
de Koning JP; Institute of Hematology, Erasmus University, Rotterdam, The Netherlands., Soede-Bobok AA, Ward AC, Schelen AM, Antonissen C, van Leeuwen D, Löwenberg B, Touw IP
Publikováno v:
Oncogene [Oncogene] 2000 Jul 06; Vol. 19 (29), pp. 3290-8.
Autor:
Ward AC; Institute of Hematology, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands. ward@hema.fgg.eur.nl, van Aesch YM, Gits J, Schelen AM, de Koning JP, van Leeuwen D, Freedman MH, Touw IP
Publikováno v:
The Journal of experimental medicine [J Exp Med] 1999 Aug 16; Vol. 190 (4), pp. 497-507.
Autor:
Ward AC; Institute of Hematology, Erasmus University, Rotterdam, The Netherlands. ward@hema.fgg.eur.nl, van Aesch YM, Schelen AM, Touw IP
Publikováno v:
Blood [Blood] 1999 Jan 15; Vol. 93 (2), pp. 447-58.
Autor:
Ward AC; Institute of Hematology, Erasmus University, Rotterdam, The Netherlands. ward@hema.fgg.eur.nl, Hermans MH, Smith L, van Aesch YM, Schelen AM, Antonissen C, Touw IP
Publikováno v:
Blood [Blood] 1999 Jan 01; Vol. 93 (1), pp. 113-24.
Autor:
de Koning JP; Institute of Hematology, Erasmus University and Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands., Soede-Bobok AA, Schelen AM, Smith L, van Leeuwen D, Santini V, Burgering BM, Bos JL, Lowenberg B, Touw IP
Publikováno v:
Blood [Blood] 1998 Mar 15; Vol. 91 (6), pp. 1924-33.
Autor:
de Koning JP; Institute of Hematology, Erasmus University, Rotterdam, The Netherlands., Dong F, Smith L, Schelen AM, Barge RM, van der Plas DC, Hoefsloot LH, Löwenberg B, Touw IP
Publikováno v:
Blood [Blood] 1996 Feb 15; Vol. 87 (4), pp. 1335-42.
Autor:
de Koning JP; Institute of Hematology, Erasmus University, Rotterdam, The Netherlands., Schelen AM, Dong F, van Buitenen C, Burgering BM, Bos JL, Löwenberg B, Touw IP
Publikováno v:
Blood [Blood] 1996 Jan 01; Vol. 87 (1), pp. 132-40.